My Commentary article “Conflicting Assumptions: The Meaning of Price in the Pharmaceutical Economy” was published in August 2017 in the journal Science As Culture. An excerpt is below. Reach out for the final version.
How does the financialization of life itself figure as a new means of producing value in modern technoscience? That is the question that motivated Kirk Fiereck to convene the panel “Biofinance: Speculation, Risk, Debt, and Value from Bios” at the 2016 American Anthropological Association meeting in Minneapolis, Minnesota last November.
I’m pleased to announce that my peer-reviewed scholarly article, titled “The Moral Life of Epinephrine in the United States,” has now been published on the open-access medical anthropology journal, Medicine Anthropology Theory!
Why do emergency medications cost so much? One answer lies in examining how financial industry stakeholders and influencers shape decision making of the people in charge of pharmaceutical sales and development.
In this recent interview with Vice, I spoke with Contributing Writer Peter Moskowitz about what makes some drugs “good” and … More
Informed by Marxist theory, feminism, and science studies, this class interrogates how drugs – both engineered pharmaceuticals and pleasurably addictive illegal substances – gain and reproduce their power in our social life. As total health expenditures approach 20% of American GDP, and drugs become dynamic components of everyday life, understanding the personal experience and political economy of these compounds is more crucial than ever.
Why is it so fun to get angry at Martin Shkreli and Turing Pharmaceuticals’ drug pricing policies? Read my take in my guest feature essay on the anthropology and STS blog Somatosphere: Why Does Everyone Hate Martin Shkreli?